• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

2.470 +0.030 (+1.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 89,224
Open 2.480
Bid (Size) 2.440 (2,000)
Ask (Size) 2.730 (600)
Prev. Close 2.440
Today's Range 2.363 - 2.570
52wk Range 0.6200 - 3.080
Shares Outstanding 124,094,390
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
March 02, 2026
Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform 
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus (NAUT) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Nautilus (NAUT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
+29.3%
+29.3%
1 Month
+22.3%
+22.3%
3 Month
+21.7%
+21.7%
6 Month
+252.4%
+252.4%
1 Year
+105.8%
+105.8%

More News

Read More
Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway ↗
February 26, 2026
Via Chartmill
News headline image
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
February 26, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For October 28, 2025 ↗
October 28, 2025
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2025 ↗
July 31, 2025
Via Benzinga
News headline image
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
February 24, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
February 19, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 05, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
January 28, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
January 08, 2026
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Which stocks are moving on Monday? ↗
November 03, 2025
Via Chartmill
News headline image
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
November 03, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus (NAUT) Q3 2025 Earnings Call Transcript ↗
October 28, 2025
Via The Motley Fool
Topics Earnings
News headline image
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
October 28, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 24, 2025
Via Benzinga
News headline image
What's going on in today's session ↗
October 21, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
October 15, 2025
Via Benzinga
News headline image
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
October 07, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
October 01, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
September 16, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 09, 2025
Via Benzinga
News headline image
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
August 27, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
July 31, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire
News headline image
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
July 30, 2025
From Nautilus Biotechnology Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Nautilus Biotechnology, Inc. - Common Stock publicly traded?
Yes, Nautilus Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Nautilus Biotechnology, Inc. - Common Stock trade on?
Nautilus Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nautilus Biotechnology, Inc. - Common Stock?
The ticker symbol for Nautilus Biotechnology, Inc. - Common Stock is NAUT on the Nasdaq Stock Market
What is the current price of Nautilus Biotechnology, Inc. - Common Stock?
The current price of Nautilus Biotechnology, Inc. - Common Stock is 2.470
When was Nautilus Biotechnology, Inc. - Common Stock last traded?
The last trade of Nautilus Biotechnology, Inc. - Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of Nautilus Biotechnology, Inc. - Common Stock?
The market capitalization of Nautilus Biotechnology, Inc. - Common Stock is 306.51M
How many shares of Nautilus Biotechnology, Inc. - Common Stock are outstanding?
Nautilus Biotechnology, Inc. - Common Stock has 307M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap